Abbott Laboratories (ABT) Change in Acquisitions & Divestments (2017)
Abbott Laboratories (ABT) reported Change in Acquisitions & Divestments of $727.0 million for Q4 2017, up 1271.7% sequentially from $53.0 million in Q3 2017.
Abbott Laboratories (ABT) Change in Acquisitions & Divestments (2017) Analysis & Trends
Abbott Laboratories (ABT) has 1 years of Change in Acquisitions & Divestments data on file, last reported at $727.0 million in Q4 2017.
- For the quarter ending Q4 2017, Change in Acquisitions & Divestments changed N/A year-over-year to $727.0 million; the trailing twelve-month figure through Dec 2017 stood at $2.7 billion (changed N/A YoY), and the FY2025 full-year result was $3.0 million, down 89.29% from the prior year.
- Change in Acquisitions & Divestments climbed to $727.0 million in Q4 2017, from $53.0 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $1.7 billion in Q1 2017 to a low of $53.0 million in Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Steris | 21.47 Bn | 21.03 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 727.00 Mn |
| Dec 31, 2017 | 727.00 Mn |
| Sep 30, 2017 | 53.00 Mn |
| Sep 30, 2017 | 53.00 Mn |
| Jun 30, 2017 | 239.00 Mn |
| Jun 30, 2017 | 239.00 Mn |
| Mar 31, 2017 | 1.69 Bn |
| Mar 31, 2017 | 1.69 Bn |